Stock Market News 2025-11-14
510 news published.
M&A and strategic deals
Merck (MRK) agreed to acquire Cidara Therapeutics, adding a late‑phase antiviral to its pipeline — a move that broadens infectious‑disease exposure and could accelerate near‑term revenue if commercialization paths materialize.
Legence (LGN) announced an agreement to buy Bowers and reported Q3 results, reshaping regional‑bank consolidation dynamics and raising integration and capital‑allocation questions for investors.
Avadel Pharmaceuticals (AVDL) received an unsolicited proposal from Lundbeck, prompting a likely strategic review that could unlock value or reprice the stock; watch Alkermes' reaction for bid dynamics.
Repare Therapeutics (RPTX) entered into a definitive agreement to be acquired by XenoTherapeutics, a transaction that could deliver a near‑term premium and reshape the competitive landscape for precision oncology assets.
Capital markets, listings and fintech flows
Charles Schwab (SCHW) released monthly activity highlights, a timely read for deposit and asset‑gathering trends across wealth and brokerage businesses.
Teamshares / Live Oak V (LOKV) is set to list via a sponsor‑led combination alongside a $126 million PIPE anchored by accounts advised by T. Rowe Price — institutional backing that could steady the debut valuation.
WeShop (WSHP) debuted on Nasdaq under ticker WSHP, a retail‑tech listing investors will watch for volume and gross‑margin execution as e‑commerce rollup narratives are tested publicly (listing details).
Energy, clean tech and project finance
Enbridge (ENB) is adding Canadian egress into major U.S. refining markets, a logistics adjustment that may influence regional feedstock flows and midstream margins.
First Solar (FSLR) selected South Carolina for a new U.S. production facility, expanding domestic module capacity and supporting utility‑scale pipeline delivery (details).
TotalEnergies (TTE) and peers highlighted climate progress at COP30 as the Oil & Gas Decarbonization Charter released its annual report, underscoring long‑run capex and emissions intensity themes investors track.
Energy transition & electrification orders
Ten‑League International Holdings (TLIH) posted a commercial win with a new order from PSA Singapore, validating its fleet electrification tech in a major regional deployment.
Nuvve Holding Corp. (NVVE) announced strategic financing to stabilize its equity base, an outcome that supports multi‑year V2G and fleet projects where balance‑sheet durability matters.
Beam Global (BEEM) released Q3 operating results, a read on order momentum and project deployment for EV charging and electrified infrastructure that investors will weigh against backlog execution risk.
Defense, aerospace and mobility
Viasat (VSAT) confirmed the successful launch of ViaSat‑3 F2, expanding capacity that could support multi‑quarter commercialization and revenue upside.
Biotech, approvals and clinical readouts
Ionis‑related DAWNZERA™ (IONS) received a positive CHMP opinion recommending EU approval for hereditary angioedema, opening a commercial pathway that may de‑risk the program.
Sarepta Therapeutics (SRPT) announced the FDA approval of updated ELEVIDYS prescribing information, a label change investors will parse for reimbursement and uptake implications.
Nuvalent (NUVL) disclosed timing for topline pivotal data for TKI pre‑treated patients from its ALKOVE‑1 study of neladalkib, a near‑term binary that could materially reprice the oncology growth outlook on readout day (timing notice).
Medical devices and cleared tech
Zimmer Biomet (ZBH) received U.S. FDA clearance for an enhanced ROSA® Knee robotic platform, a potential commercial catalyst for surgical‑robotics adoption.
Corporate actions, offerings and governance
Verastem Oncology (VSTM) priced a $90 million public offering and pre‑funded warrants to extend runway for clinical programs; dilution is immediate but buys time for development milestones.
TriMas (TRS) increased its share repurchase authorization to $150 million, a capital‑allocation move that could support EPS if executed with balance‑sheet discipline (announcement).
Treasure Global (TGL) said major shareholders agreed to a 12‑month voluntary lock‑up covering over 51% of shares, a governance action that materially reduces free float and can compress short‑term liquidity.
Waldencast plc (WALD) strengthened its balance sheet with a trademark sale in Japan and refinancing of credit facilities, a financing step investors will watch for runway and restructuring optionality.
NN, Inc. (NNBR) provided a mid‑quarter business update, helpful context for demand trends and near‑term guidance visibility in industrial components.
Earnings and notable quarterly results
Today's calendar was heavy with small‑cap reports that tweak cash, backlog and execution narratives. Key items to note:
- Cineverse (CNVS) reported Q2 FY2026 results — subscribers and content spend remain the focus for valuation resets (release).
- PetVivo (PETV) posted fiscal Q2 2026 with revenues up 50%, a rare top‑line acceleration for a small biomed name that may shift short‑term investor interest (read).
- Jet.AI (JTAI) released Q3 results and shared progress on a Canadian hyperscale data center milestone, relevant to its infrastructure roadmap (details).
- Sidus Space (SIDU) reported Q3 financials and a business update — investors should watch contract cadence and cash‑burn assumptions in the smallsat services play (release).
- OMNIQ (OMQS) posted third‑quarter financials; results offer a read on biometric and AI‑security demand for industrial customers (statement).
- Eledon Pharmaceuticals (ELDN) issued recent business highlights alongside Q3 results, useful for gauging clinical spend and cash runway (details).
- XMax Inc. (NVFY) reported Q3 results, a micro‑cap update that refines near‑term cash and revenue traction expectations (release).
- Benitec Biopharma (BNTC) released Q1 FY2026 results and an operational update that investors will parse for program timing and dilution risk (read).
- Medicus Pharma Ltd. (MDCX) reported Q3 financial highlights and corporate updates, relevant for niche pharma exposure (release).
- Maui Land & Pineapple (MLP) filed fiscal Q3 2025 results — small‑cap hospitality/land updates that adjust cash and asset‑monetization expectations (results).
Regulatory, utilities and large cap infrastructure
Pennsylvania American Water (part of American Water Works via AWK) filed a rate request driven by more than $1.2 billion in ongoing investment to maintain safe, reliable service; higher allowed rates would materially affect regulated utility cash flow and investor yield expectations (filing).
Product launches, partnerships and services
Fathom (FTHM) announced a strategic partnership with Move Concierge to boost buyer services — a distribution tie that can lift lead conversion and transaction economics in real‑estate services (details).
Compliance, governance and market structure
Actelis Networks (ASNS) announced a reverse stock split, a capital‑structure step often taken to regain exchange compliance or broaden institutional interest.
IceCure Medical (ICCM) received a Nasdaq minimum bid price notification, a compliance flag that investors should watch for potential remediation steps or further exchange action.
BiomX Inc. (PHGE) announced a 1‑for‑19 reverse stock split, a typical governance move to regain listing standards but one that materially alters share counts and float dynamics.
Debt markets and corporate finance
Unum Group (UNM) completed a senior notes offering, an execution that bolsters liquidity and adjusts the insurer’s maturity profile; investors will weigh the cost of debt against capital return and reserve plans.
Other notable small‑cap updates
Additional smaller operational updates today included XTI Aerospace (XTIA)'s rescheduled town hall on strategic initiatives and several routine quarterly filings that refine cash and runway assumptions across micro‑caps. Investors should prioritize items that change runway, cash flow or strategy materially.
Stay ahead of the market with our list of today's most important stock news and financial updates. Whether you're a day trader, long-term investor, or market enthusiast, our news feed covers everything you need to know about publicly traded companies.
Our news feed is designed for investors who want to stay informed about the latest developments affecting their portfolio or watchlist. Whether you're researching potential investments, monitoring your current holdings, or simply staying up-to-date with market trends, our stock news page provides the information you need to make informed decisions.
What You'll Find on This Page:
- Breaking financial news and market-moving headlines
- FDA approvals and clinical trial results for biotech and pharma stocks
- Stock offerings, dividends, and other corporate actions
- Mergers, acquisitions, and strategic partnerships
- Business news affecting company performance and stock prices
- Easy-to-use tags for quick news categorization
- Stock tickers for instant company identification
- AI sentiment analysis to gauge market reaction
- Estimated impact scores to assess potential stock movement